We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
In a Site Selection Magazine article, Managing Director Tracey Hyatt Bosman shares her outlook for 2025's greatest workforce challenges:
A Silver Tsunami is Coming
Tracey Hyatt Bosman, managing director at location advisory firm Biggins Lacy Shapiro & Co., says that while some job markets around the U.S. have softened, there is still room for improvement. “In most markets, it’s easier to find workers now than it was two years ago,” she says. “But it’s still not easy, and it’s not forecast to get easier in the next few years. Further, companies don’t just need workers; they need workers with the right skills. This will continue the pressure on companies to consider automation as a potential response. It also puts pressure on communities to consider talent attraction, upskilling and training strategies.”
Tracey Hyatt Bosman develops and executes incentives and location selection strategies for BLS & Co.'s corporate and institutional clients. She is a certified economic developer with twenty years of professional experience across a wide range of sectors, including data centers, manufacturing, headquarters, back office and contact center operations, and logistics.
This piece explores how pharma’s next investment cycle may shift toward modernizing, repurposing and optimizing existing manufacturing capacity, creating new opportunities for companies and communities in the 2030s.
Drawing on BLS’s experience advising major pharmaceutical manufacturers, this piece explores how workforce capacity, site readiness, reliable utilities and public investment shaped location decisions during the U.S. pharma manufacturing boom.
Part one of our three part analysis of the life sciences industry examines how scientific innovation, tax reform, industrial policy and federal pricing and trade pressures converged to drive the wave of U.S. pharmaceutical manufacturing investment in the 2020s.
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.